Results from CHOP Study, Licensed to Medgenics, Link mGluR Pathway CNVs to Risk of Syndromic Autism | GenomeWeb

NEW YORK (GenomeWeb) – Researchers led by the Children's Hospital of Philadelphia have linked alterations in the gene RANBP1 to an individual's risk for developing severe subtypes of autism that tend to co-occur with other genetic diseases.

The team, led by Hakon Hakonarson, director of the Center for Applied Genomics at CHOP, published its results this week in Scientific Reports. CHOP has been collaborating with Medgenics to develop new treatments for rare pediatric genetic diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.